Gentian Diagnostics ASA (OSL:GENT)
34.90
-0.50 (-1.41%)
Jun 25, 2026, 9:00 AM CET
Gentian Diagnostics ASA Market Cap
Gentian Diagnostics ASA has a market cap or net worth of 547.24 million as of June 25, 2026. Its market cap has decreased by -40.46% in one year.
Market Cap
547.24M
Enterprise Value
473.06M
Revenue
175.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.90
Market Cap Chart
Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 547.24M, an increase of 88.95%. That is a compound annual growth rate of 6.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 547.24M | -37.09% |
| Dec 30, 2025 | 869.82M | 43.88% |
| Dec 30, 2024 | 604.56M | -5.54% |
| Dec 29, 2023 | 640.03M | 1.22% |
| Dec 30, 2022 | 632.32M | -43.06% |
| Dec 30, 2021 | 1.11B | 32.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.08B |
| Circio Holding ASA | 1.99B |
| Nordhealth AS | 1.72B |
| Photocure ASA | 1.60B |
| ArcticZymes Technologies ASA | 1.03B |
| Vistin Pharma ASA | 909.06M |
| INIFY Laboratories AB | 859.80M |
| Omda AS | 740.33M |